Sodium disorders

Warning

Objectives

Manage low sodium levels on operations

Scope

Initial management of symptomatic low sodium in the deployed environment

Audience

Clinical decision makers in R1-R3

Initial Assessment & Management

Clinical features:

Excessive lethargy ('somnolence') Confusion
Headache Seizures
Nausea Reduced GCS, loss of consciousness, coma
Vomiting Cardiorespiratory distress
Irritability  

Worsening symptoms suggest cerebral oedema, which is a medical emergency

Classification:

Na <130 mmol/l

  • Mild: Na 125-129 mmol/l
  • Moderate: Na 115 – 125 mmol/l
  • Severe: Na <115 mmol/l or mild symptoms

ACUTE = onset <48 hours/ Na fallen >10mmol/l in 48 hours

CHRONIC = onset >48 hours or not known

Often chronicity is unknown so it is safer to treat as chronic

Na <120

ANY acute or severe symptoms (vomiting, seizure, cardiorespiratory arrest, deep/ abnormal somnolence); AND no other cause for symptoms identified:

  • Administer hypertonic saline* IV over 20 mins
  • Indication is to improve symptoms NOT correct Na back to normal
  • If no clinical improvement after 20 mins and Na remains the same, a repeat dose may be given
  • Extreme caution about over-correcting which may induce central demyelination. Target sodium improvement of 5-8 mmol/L; max 10mmol/L OVER 24 hours – no faster. If over-corrected start 5% dextrose 10 ml/kg/h while seeking specialist advice ASAP

Refer to next role*Hypertonic saline. Where 3% saline unavailable, dilute 50ml of 5% saline in 50ml 0.9% saline (remove 50ml from 100ml 0.9% saline bag); give 100ml over 20 mins through a large bore cannula.

 

 

Advanced Assessment & Management

Na >120. Proceed to investigate non-urgently as follows:

Exclude non-sodium causes. High glucose temporarily displaces sodium and does not cause cerebral oedema; follow hyperglycaemia guideline. Significant (visible) dyslipidaemia may be pseudohyponatraemia (normal osmolality). Seek routine specialist support.

Clinical assessment. The treatment of hyponatraemia depends on the volume status (however clinicians are poor at assessing this. Where possible request urine sodium).

  • Assess fluid status
  • Measure glucose, blood osmolality, urine osmolality, lipids if available
  • If possible, ask BMS to give an indicative urine sodium (run using Benchtop biochem analyser). If undetected on serum analyser, assume cause is dehydration
  • Urinalysis – check for renal disease
  • Refer to next role for full workup

 

Hypovolaemic (Low BP, dehydrated)

  • Dehydration (GI losses commonest cause; low urine sodium on serum analyser)
  • Diarrhoea and vomiting (low urine sodium on serum analyser)
  • Diuretics or kidney disease (detectable urine sodium on serum analyser)
  • Primary adrenal insufficiency (detectable urine sodium on serum analyser)

Treatment with IV 0.9% saline, 125-250 ml/h (send urine sodium before initiating)

 

Euvolaemic (warm, well perfused)

  • Primary polydipsia or low salt intake (urine osmolality <100)
  • Diuretics or kidney disease (detectable urine sodium)
  • SIADH (no other cause found; urine sodium >30mmol/L)
  • Hypothyroid, secondary adrenal insufficiency*
  • Chronic alcoholism

Consider admission to monitor fluid balance and sodium; fluid restrict 1.5L. Seek specialist advice via reachback.

 

Hypervolaemic (volume expanded, i.e. elevated jugular venous pressure/ oedematous/ other evidence of congestive cardiac failure)

  • Fluid overload (low urine sodium)
  • Heart failure
  • Chronic kidney disease
  • Liver failure/ ascites
  • Low albumin

Treat underlying cause.

Last reviewed: 26/02/2026

Next review date: 26/02/2027